Przemyslaw Jarzebowski

University College London

A headshot of a smiling main with brown hair and facial hair.

Dr Przemyslaw (Prez) Jarzebowski is a Research Fellow at University College London, where he has been a member of Professor Dan Bendor’s laboratory since 2022.

His research focuses on the auditory system, specifically how past hearing experience influences how the brain processes sound information.

More about Prez’s work

Dr Jarzebowski completed his PhD in 2022 from the University of Cambridge. Before transitioning to neuroscience, he trained and gained experience in computer engineering, which continues to inform his multidisciplinary approach to research. Prez is an RNID-Vivensa Foundation Fellow.

Predictive hearing – how the brain compensates for degraded sound information

Read about Prez’s research project

Prez’s hopes for the future of hearing research

Why have you chosen to work in hearing research? 

The path leading me to hearing research was not straightforward and involved a series of coincidences – all of which I’m grateful for. I find work in this field incredibly motivating as any advances in hearing research hold the potential to make a real, lasting difference in the lives of people affected by hearing loss.

What do you hope your research will achieve? 

I hope my research will shed light on how brain signals generated by sounds interact with those generated internally, for example, by predictions about upcoming sounds. This process is crucial for normal hearing but likely even more so when the processing of sounds is affected by age-related hearing loss.

In the long term, this knowledge could help to design new interventions that improve hearing by selectively targeting the brain’s predictions about sounds.

What does RNID/Vivensa Foundation funding mean to you?

I am incredibly grateful for the funding invested in me and the project I proposed. This support allows me to build on my research and direct its focus towards age-related hearing loss – a direction I find deeply meaningful due to its potential for translational benefits.

Related

Page last updated: 14 January 2026

Back to top